$80,000 of ENTEGRIS INC. lobbying was just disclosed, from Q1 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167); issues connected to potential reintroduction of H.R. 6207/S.3301 -the Chip Equipment Quality, Usefulness, and Integrity Protection (Chip EQUIP) Act of 2025. Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167); issues connected to potential reintroduction of H.R. 6207/S.3301 -the Chip Equipment Quality, Usefulness, and Integrity Protection (Chip EQUIP) Act of 2025. Issues related to implementation of the CHIPS and Science Act (Pub. L. 117-167). Issues related to Section 48D of the Internal Revenue Code and Section 107 of the Chips and Science Act; S. 1642 and H.R. 6055 (Strengthening Essential Manufacturing and Industrial Investment Act). Issues related to export control policy relevant to the semiconductor supply chain ecosystem."
You can find more data on corporate lobbying on Quiver Quantitative.
ENTG Congressional Stock Trading
Members of Congress have traded $ENTG stock 6 times in the past 6 months. Of those trades, 2 have been purchases and 4 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by members of Congress over the last 6 months:
- REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 3 times. They made 1 purchase worth up to $15,000 on 03/31 and 2 sales worth up to $30,000 on 02/23, 02/09.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 3 times. They made 1 purchase worth up to $15,000 on 10/30 and 2 sales worth up to $30,000 on 10/31, 10/30.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
ENTG Insider Trading Activity
ENTG insiders have traded $ENTG stock on the open market 31 times in the past 6 months. Of those trades, 0 have been purchases and 31 have been sales.
Here’s a breakdown of recent trading of $ENTG stock by insiders over the last 6 months:
- BERTRAND LOY (Executive Chair) has made 0 purchases and 16 sales selling 232,658 shares for an estimated $27,415,353.
- DANIEL D. WOODLAND (SVP & President, MS Division) has made 0 purchases and 3 sales selling 30,474 shares for an estimated $3,981,313.
- LINDA LAGORGA (SVP, Chief Financial Officer) sold 11,438 shares for an estimated $1,544,130
- JOSEPH COLELLA (SVP and General Counsel) has made 0 purchases and 4 sales selling 6,749 shares for an estimated $707,984.
- CLINTON M. HARIS (SVP & President, APS Division) sold 5,830 shares for an estimated $699,600
- OLIVIER BLACHIER (SVP, Chief Strategy Officer) has made 0 purchases and 5 sales selling 2,427 shares for an estimated $288,366.
- JAMES P LEDERER sold 2,008 shares for an estimated $186,422
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
ENTG Hedge Fund Activity
We have seen 255 institutional investors add shares of ENTG stock to their portfolio, and 295 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DURABLE CAPITAL PARTNERS LP removed 3,765,035 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $317,204,198
- LONE PINE CAPITAL LLC added 3,054,230 shares (+inf%) to their portfolio in Q4 2025, for an estimated $257,318,877
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,873,516 shares (-74.5%) from their portfolio in Q4 2025, for an estimated $157,843,723
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,625,815 shares (-91.1%) from their portfolio in Q4 2025, for an estimated $136,974,913
- D1 CAPITAL PARTNERS L.P. added 1,343,435 shares (+116.8%) to their portfolio in Q4 2025, for an estimated $113,184,398
- SOUTHPOINT CAPITAL ADVISORS LP removed 1,300,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $109,525,000
- UBS GROUP AG removed 1,024,804 shares (-30.1%) from their portfolio in Q4 2025, for an estimated $86,339,737
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
ENTG Analyst Ratings
Wall Street analysts have issued reports on $ENTG in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/10/2026
- Citigroup issued a "Buy" rating on 01/27/2026
- BMO Capital issued a "Outperform" rating on 01/21/2026
- UBS issued a "Buy" rating on 01/15/2026
- Keybanc issued a "Overweight" rating on 01/09/2026
To track analyst ratings and price targets for ENTG, check out Quiver Quantitative's $ENTG forecast page.
ENTG Price Targets
Multiple analysts have issued price targets for $ENTG recently. We have seen 8 analysts offer price targets for $ENTG in the last 6 months, with a median target of $145.0.
Here are some recent targets:
- Aleksey Yefremov from Keybanc set a target price of $156.0 on 02/11/2026
- Elizabeth Sun from Citigroup set a target price of $155.0 on 02/11/2026
- James Schneider from Goldman Sachs set a target price of $95.0 on 02/11/2026
- Charles Shi from Needham set a target price of $150.0 on 02/10/2026
- Bhavesh Lodaya from BMO Capital set a target price of $126.0 on 01/21/2026
- Timothy Arcuri from UBS set a target price of $145.0 on 01/15/2026
- John Roberts from Mizuho set a target price of $96.0 on 11/20/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
